| 摘要 |
Compounds of formula (I) and pharmaceutically acceptable salts thereof, where R is CO2R12 and R12 is H or a biolabile ester-forming group or R is tetrazol-5-yl and either (a) R1 is (Ia) and R2 is F, Cl, Br, I, CH3 or CF3 or (b) R1 is C3-C6 alkyl and R2 is C2-C4 alkyl, are selective 5-.alpha.-reductase-1 inhibitors.
|
